Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Zocor UK ad

This article was originally published in The Tan Sheet

Executive Summary

Johnson & Johnson MSD has amended a print advertisement for ZocorHeart-Pro (simvastatin 10 mg) that contained the phrase "protection of hearts" and had not been submitted to the MHRA for "pre-vetting," the Medicines & Healthcare products Regulatory Agency announces Oct. 29. The UK health agency cited the ad because the phrase "fails to convey to the reader that Zocor Heart-Pro does not provide absolute protection from risk of heart attack and that it should [be] taken in conjunction with lifestyle changes." J&J MSD said the "error had resulted from a failure in [the firm's] internal procedures over the holiday period" and ensured the problem "would not happen again"...

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS097471

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel